A series of transforaminal epidural steroid injections in acute lumbar disc herniation with unilateral radiculopathy

Jay Turakhiya, Himanshu Parmar, Kushal Zala, N. Maru, Anant Prajapati
{"title":"A series of transforaminal epidural steroid injections in acute lumbar disc herniation with unilateral radiculopathy","authors":"Jay Turakhiya, Himanshu Parmar, Kushal Zala, N. Maru, Anant Prajapati","doi":"10.4103/jodp.jodp_18_22","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate functional outcomes of patients suffering from unilateral lower limb radiculopathy due to lumbar disc herniation conservatively treated with transforaminal epidural steroid injection (TFESI). Materials and Methods: It is a prospective study of 100 patients. We correlated clinical findings with magnetic resonance imaging. The patients are treated with dexamethasone injection through transforaminal epidural space under C-ARM guidance using Kambin's triangle approach with follow-up at 3 weeks, 6 weeks, 9 weeks, 12 weeks, and 24 weeks. Assessment of functional outcomes is done by visual analog scale (VAS) and modified Oswestry disability index (ODI). Results: Eighty-eight percent of patients significantly improved their radicular pain, according to the VAS scoring system and modified ODI. The mean modified ODI score of preinjection was found to be 64.18; it was reduced to 33.9 at 3 weeks, 30.82 at 6 weeks, 24.04 at 9 weeks, 22.04 at 12 weeks, and 19.38 at 6 months. The t = 18.49 and the P < 0.00001. Preinjection mean VAS was 8, 3.98 at 3 weeks, 3.28 at 6 weeks, 3.04 at 9 weeks, 2.72 at 12 weeks, and reduced to 2.14 at 24 weeks. The t = 19.83 and the P < 0.00001. There were no complications seen during our study. Conclusion: Our study justifies that unilateral lower limb radiculopathy due to lumbar disc herniation can be well managed by TFESI without any complication. It is very less invasive technique, safe, and effective for pain relief.","PeriodicalId":34809,"journal":{"name":"Journal of Orthopaedic Diseases and Traumatology","volume":"5 1","pages":"162 - 166"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Orthopaedic Diseases and Traumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jodp.jodp_18_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate functional outcomes of patients suffering from unilateral lower limb radiculopathy due to lumbar disc herniation conservatively treated with transforaminal epidural steroid injection (TFESI). Materials and Methods: It is a prospective study of 100 patients. We correlated clinical findings with magnetic resonance imaging. The patients are treated with dexamethasone injection through transforaminal epidural space under C-ARM guidance using Kambin's triangle approach with follow-up at 3 weeks, 6 weeks, 9 weeks, 12 weeks, and 24 weeks. Assessment of functional outcomes is done by visual analog scale (VAS) and modified Oswestry disability index (ODI). Results: Eighty-eight percent of patients significantly improved their radicular pain, according to the VAS scoring system and modified ODI. The mean modified ODI score of preinjection was found to be 64.18; it was reduced to 33.9 at 3 weeks, 30.82 at 6 weeks, 24.04 at 9 weeks, 22.04 at 12 weeks, and 19.38 at 6 months. The t = 18.49 and the P < 0.00001. Preinjection mean VAS was 8, 3.98 at 3 weeks, 3.28 at 6 weeks, 3.04 at 9 weeks, 2.72 at 12 weeks, and reduced to 2.14 at 24 weeks. The t = 19.83 and the P < 0.00001. There were no complications seen during our study. Conclusion: Our study justifies that unilateral lower limb radiculopathy due to lumbar disc herniation can be well managed by TFESI without any complication. It is very less invasive technique, safe, and effective for pain relief.
一系列经椎间孔硬膜外类固醇注射治疗急性腰椎间盘突出症伴单侧神经根病
目的:评价经椎间孔硬膜外类固醇注射(TFESI)保守治疗腰椎间盘突出症所致单侧下肢神经根病的疗效。材料和方法:这是一项对100名患者的前瞻性研究。我们将临床发现与磁共振成像相关联。患者在C-ARM指导下,采用Kambin三角形入路,通过经孔硬膜外腔注射地塞米松进行治疗,随访时间分别为3周、6周、9周、12周和24周。通过视觉模拟量表(VAS)和改良的奥斯韦斯特里残疾指数(ODI)对功能结果进行评估。结果:根据VAS评分系统和改良ODI,88%的患者的神经根疼痛得到了显著改善。注射前ODI的平均修正得分为64.18;3周时降至33.9,6周时降至30.82,9周时降至24.04,12周时降至22.04,6个月时降至19.38。t=18.49,P<0.00001。注射前平均VAS为8,3周时为3.98,6周时为3.28,9周时为3.04,12周时为2.72,24周时降至2.14。t=19.83,P<0.00001。在我们的研究中没有发现并发症。结论:我们的研究证明,TFESI可以很好地治疗腰椎间盘突出症引起的单侧下肢神经根病,没有任何并发症。这是一种微创、安全、有效的止痛技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
26
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书